659.6

-1.17%↓

ALV

289.8

-0.55%↓

SAF

207

-1.38%↓

BBVA

9.342

+1.24%↑

64.36

-0.92%↓

659.6

-1.17%↓

ALV

289.8

-0.55%↓

SAF

207

-1.38%↓

BBVA

9.342

+1.24%↑

64.36

-0.92%↓

659.6

-1.17%↓

ALV

289.8

-0.55%↓

SAF

207

-1.38%↓

BBVA

9.342

+1.24%↑

64.36

-0.92%↓

659.6

-1.17%↓

ALV

289.8

-0.55%↓

SAF

207

-1.38%↓

BBVA

9.342

+1.24%↑

64.36

-0.92%↓

659.6

-1.17%↓

ALV

289.8

-0.55%↓

SAF

207

-1.38%↓

BBVA

9.342

+1.24%↑

64.36

-0.92%↓

Kodu・Aktsiate loetelu・Bayer AG

Bayer AG

Suletud

Sektor Rahandus

29.745 -2.03

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

29.71

Max

30.48

Põhinäitajad
By Trading Economics
Sissetulek	-2B -34M
Müük	-2.6B 11B
P/E Sektori keskmine	30.9 17.879
Aktsiakasum	0.94
Kasumimarginaal	-0.305
EBITDA	-2.6B 1.7B

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	-0.95 downside

Turustatistika
By TradingEconomics
Turukapital	-216M 30B
Eelmine avamishind	31.78
Eelmine sulgemishind	29.745

Uudiste sentiment

By Acuity

27%

73%

114 / 461 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

30.385 / 30.985 Toetus ja vastupanu

Bayer AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. aug 2024, 08:28 UTC

Suurimad hinnamuutused turgudel

Bayer Shares Surge After Appeal Win in Roundup Cancer Suit

15. aug 2024, 21:43 UTC

Tulu

Bayer's Monsanto Wins Appeal in Roundup Cancer Suit

6. aug 2024, 10:56 UTC

Tulu

Bayer Posts Net Loss as Tough Agriculture Market Bites -- Update

6. aug 2024, 09:00 UTC

Tulu

Correction to Bayer Article

6. aug 2024, 06:29 UTC

Tulu

Bayer Posts Net Loss, Dragged by Weaker Crop-Science Performance

14. mai 2024, 13:21 UTC

Tulu

Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update

14. mai 2024, 06:13 UTC

Tulu

Bayer Net Profit Falls on Lower Sales, Currency Headwinds

23. aug 2024, 08:51 UTC

Market Talk

BMW's EV Coup Over Tesla in Europe Shows Strength as Tesla Products Age -- Market Talk

16. aug 2024, 14:21 UTC

Market Talk

Bayer's Appeal Win Could Be First Step to End Roundup Litigation -- Market Talk

16. aug 2024, 08:58 UTC

Tulu

Kuumad aktsiad

Stocks to Watch Friday: Applied Materials, H&R Block, Bayer, Bavarian Nordic -- WSJ

6. aug 2024, 10:47 UTC

Market Talk

Bayer Could Face Consensus Earnings Downgrades Amid Currency Headwinds -- Market Talk

6. aug 2024, 08:55 UTC

Market Talk

Tulu

Bayer's 2Q Beat Boosted By Pharma Business -- Market Talk

6. aug 2024, 08:20 UTC

Market Talk

Tulu

Bayer's 2Q Results Are a Mixed Bag -- Market Talk

6. aug 2024, 06:57 UTC

Market Talk

Tulu

Bayer 2Q Results Could Lead to Muted Share Price Response -- Market Talk

6. aug 2024, 05:34 UTC

Tulu

Bayer Saw 2024 Core EPS Between EUR5.10 and EUR5.50

6. aug 2024, 05:34 UTC

Tulu

Bayer Saw 2024 Ebitda Before Special Between EUR10.7B and EUR11.3B

6. aug 2024, 05:33 UTC

Tulu

Bayer Backs 2024 View

6. aug 2024, 05:33 UTC

Tulu

Analysts Saw Bayer 2Q Ebitda Before Special Items at EUR2.08B

6. aug 2024, 05:33 UTC

Tulu

Bayer 2Q Ebitda Before Special Items EUR2.11B

6. aug 2024, 05:32 UTC

Tulu

Analysts Saw Bayer 2Q Net Pft at EUR70M

6. aug 2024, 05:32 UTC

Tulu

Bayer 2Q Net Loss EUR34M

6. aug 2024, 05:31 UTC

Tulu

Analysts Saw Bayer 2Q Core EPS at EUR0.84

6. aug 2024, 05:31 UTC

Tulu

Bayer 2Q Core EPS EUR0.94

6. aug 2024, 05:31 UTC

Tulu

Bayer 2Q EBIT EUR525M

6. aug 2024, 05:30 UTC

Tulu

Analysts Saw Bayer 2Q Rev at EUR10.82B

6. aug 2024, 05:30 UTC

Tulu

Bayer 2Q Rev EUR11.14B

12. juuli 2024, 07:05 UTC

Market Talk

Bayer's Cost-Savings and Cash Delivery Key Focus for 2Q -- Market Talk

5. juuni 2024, 09:57 UTC

Kuumad aktsiad

Stocks to Watch Wednesday: CrowdStrike, HPE, Dollar Tree -- WSJ

14. mai 2024, 11:00 UTC

Market Talk

Tulu

Bayer Earnings Show Progression on Turnaround Strategy -- Market Talk

14. mai 2024, 05:34 UTC

Tulu

Bayer Backs 2024 Currency-Adjusted Outlook

Võrdlus sarnastega

Hinnamuutus

Bayer AG Prognoos

Hinnasiht

By TipRanks

-0.95% langus

12 kuu keskmine prognoos

Keskmine 30.11 EUR -0.95%

Kõrge 34 EUR

Madal 26 EUR

Põhineb 11 Wall Streeti analüütiku instrumendi Bayer AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi Bayer AG aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

30.385 / 30.985Toetus ja vastupanu

Bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

114 / 461 Pingereas Rahandus

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

Ettevõttest Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non